Similar articles

• Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.

  Sanduleanu S, Jonkers D, De Bruïne A, Hameeteman W, Stockbrügger RW. Sanduleanu S, et al. Aliment Pharmacol Ther. 2001 Aug;15(8):1163-75. doi: 10.1046/j.1365-2036.2001.01029.x. Aliment Pharmacol Ther. 2001. PMID: 11472319
• Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice.

  Rood JC, Ruiz B, Fontham ET, Malcom GT, Hunter FM, Sobhan M, Johnson WD, Correa P. Rood JC, et al. Nutr Cancer. 1994;22(1):65-72. doi: 10.1080/01635589409514332. Nutr Cancer. 1994. PMID: 11304911
• The gastric microenvironment determines Helicobacter pylori colonization.

  Correa P. Correa P. Am J Gastroenterol. 1995 Sep;90(9):1379-81. Am J Gastroenterol. 1995. PMID: 7661153 No abstract available.
• Effects of acid suppression on microbial flora of upper gut.

  Yeomans ND, Brimblecombe RW, Elder J, Heatley RV, Misiewicz JJ, Northfield TC, Pottage A. Yeomans ND, et al. Dig Dis Sci. 1995 Feb;40(2 Suppl):81S-95S. doi: 10.1007/BF02214873. Dig Dis Sci. 1995. PMID: 7859586 Review.
• The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions.

  Smith JL. Smith JL. J Food Prot. 2003 Jul;66(7):1292-303. doi: 10.4315/0362-028x-66.7.1292. J Food Prot. 2003. PMID: 12870767 Review.